Evidence map›Paper›PMID 33478061›Full record

ArticleMarine drugs2021

A Conantokin Peptide Con-T[M8Q] Inhibits Morphine Dependence with High Potency and Low Side Effects.

Zhuguo Liu, Zheng Yu, Shuo Yu, Cui Zhu, Mingxin Dong, Wenxiang Mao, Jie Hu, Mary Prorok, Ruibin Su, Qiuyun Dai

Open access · goldAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Zhuguo LiuBeijing Institute of Biotechnology, Beijing 100071, China.
Zheng YuBeijing Institute of Biotechnology, Beijing 100071, China.
Shuo YuBeijing Institute of Biotechnology, Beijing 100071, China.
Cui ZhuBeijing Institute of Biotechnology, Beijing 100071, China.
Mingxin DongBeijing Institute of Biotechnology, Beijing 100071, China.
Wenxiang MaoBeijing Institute of Biotechnology, Beijing 100071, China.
Jie HuBeijing Institute of Biotechnology, Beijing 100071, China.
Mary ProrokDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, USA.
Ruibin SuBeijing Institute of Toxicology and Pharmacology, Beijing 100850, China.
Qiuyun DaiBeijing Institute of Biotechnology, Beijing 100071, China.ORCID 0000-0003-2062-8332
University of Notre Dame · US

Funding

the National Natural Science Foundation of China 81473192 and 81173035
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsConotoxinsDisease Models, AnimalExcitatory Amino Acid AntagonistsHippocampusLocomotionMaleMiceMorphine DependenceNaloxonePiperidinesReceptors, N-Methyl-D-AspartateSpatial Memoryconantokin-TConotoxinsExcitatory Amino Acid AntagonistsifenprodilNaloxoneNR2B NMDA receptorPiperidinesReceptors, N-Methyl-D-Aspartateconantokincon-T[M8Q]morphine dependenceNMDA receptor GluN2B subunit

Identifiers

PMID33478061
PMCPMC7835912
OpenAlexW3124215427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.